References
- Kurjak A. Intrauterini zastoj rasta. In: Kurjak A, Kuvačić I, Đelmiš J, eds. Porodništvo. 1st ed. Zagreb: Medicinska naklada; 2009:351–7
- Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;4:219–27
- Straszewski-Chavez SL, Abrahams VM, Mor G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 2005;26:877–97
- Roje D, Tomas SZ, Prusac IK, et al. Trophoblast apoptosis in human term placentas from pregnancies complicated with idiopathic intrauterine growth retardation. J Matern Fetal Neonatal Med 2011;24:745–51
- Gourvas V, Dalpa E, Konstantinidou A, et al. Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction (review). Mol Med Rep 2012;6:23–7
- Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnan 2012;2012:1–7
- Huppertz B, Kingdom JCP. Apoptosis in the trophoblast – role of apoptosis in placental morphogenesis. J Soc Gynecol Investig 2004;11:353–62
- Barut F, Barut A, Gun BD, et al. Intrauterine growth restriction and placental angiogenesis. Diagn Pathol 2010;5:24–31
- Whitley GS, Cartwright JE. Trophoblast-mediated spiral artery remodelling: a role for apoptosis. J Anat 2009;215:21–6
- Neale DM, Mor G. The role of Fas mediated apoptosis in preeclampsia. J Perinat Med 2005;33:471–7
- Bamberger AM, Schulte HM, Thuneke I, et al. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997;82:3173–5
- Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189–92
- Bohana-Kashtan O, Civin CI. Fas ligand as a tool for immunosuppression and generation of immune tolerance. Stem Cells 2004;22:908–24
- Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011;141:715–24
- Uckan D, Steele A, Cherry, et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997;3:655–62
- Roje D, Tadin I, Marusic J, et al. Porodne tezine i duljine novorodjencadi u Splitu, opravdanost razvijanjanja vlastitih referentnih vrijednosti za ocjenjivanje fetalnog rasta. Gynaecol Perinatol 2005;14:66–74
- Allaire AD, Ballenger KA, Wells SR, et al. Placental apoptosis in preclampsia. Obstet Gynecol 2000;96:271–6
- Bonett DG, Price RM. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Method 2002;7:370–83
- Hu WS, Wang ZP, Dong MY, Wang HZ. Expression of Fas and FasL in serum and placenta of preeclamptic pregnancy and its significance. Zhejiang Da Xue Xue Bao Yi Xue Ban 2005;34:499–502
- Koenig JM, Chegini N. Enhanced expression of Fas-associated proteins in decidual and trophoblastic tissues in pregnancy-induced hypertension. Am J Reprod Immunol 2000;44:347–9
- Tomas SZ, Roje D, Prusac IK, et al. Morphological characteristics of placentas associated with idiopathic intrauterine growth retardation: a clinicopathologic study. Eur J Obstet Gynecol Reprod Biol 2010;152:39–43
- Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997;158:4122–8
- Darmochwal-Kolarz D, Saito S, Rolinski J, et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 2007;58:39–45
- Eide IP, Isaksen CV, Salvesen KA, et al. Fetal growth restriction is associated with reduced FasL expression by decidual cells. J Reprod Immunol 2007;74:7–14